2-chloroadenosine has been researched along with Leukemia, Hairy Cell in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.86) | 18.7374 |
| 1990's | 27 (77.14) | 18.2507 |
| 2000's | 6 (17.14) | 29.6817 |
| 2010's | 1 (2.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argnani, L; Baccarani, M; Broccoli, A; Derenzini, E; Gandolfi, L; Pellegrini, C; Pileri, S; Quirini, F; Stefoni, V; Zinzani, PL | 1 |
| Ferrari, J; Lang, W; Müllauer, L; Raderer, M; Thurnher, S | 1 |
| Januszewicz, H; Quach, H; Westerman, D | 1 |
| Beauregard, P; Dufresne, J; Knecht, H; St-Hilaire, E; Viens, D | 1 |
| Estey, EH; Jaiyesimi, IA; Kantarjian, HM | 1 |
| Geisen, F; Grünewald, K; Konwalinka, G; Schirmer, M; Thaler, J; Umlauft, F; Vogel, W; Zilian, U | 1 |
| Boogaerts, MA; De Wolf-Peeters, C; Maes, A; Pittaluga, S; Verhoef, G | 1 |
| Beutler, E; Carson, DA | 1 |
| Dann, EJ; Polliack, A | 1 |
| Birtolo, S; Bocchia, M; Forconi, F; Lauria, F; Marotta, G; Raspadori, D; Rondelli, D; Salvucci, M; Tura, S; Ventura, MA; Zinzani, PL | 1 |
| Chrobák, L; Podzimek, K; Stránský, P; Zák, P | 1 |
| Barak, V; Dinarello, CA; Nisman, B; Polliack, A; Vannier, E | 1 |
| Amoroso, V; Baccarani, M; Beltrami, CA; Damiani, D; Di Loreto, C; Fanin, R; Infanti, L; Mariuzzi, L; Russo, D; Salmaso, F; Silvestri, F; Zaja, F | 1 |
| Flandrin, G; Maloisel, F; Troussard, X | 1 |
| Bacchi, M; Betticher, DC; Cerny, T; Hess, U; Ratschiller, D; Sperb, RA; Tichelli, A; Tobler, A; von Rohr, A | 1 |
| Barak, V; Nisman, B; Polliack, A | 1 |
| Gushiken, FC | 1 |
| Abhyankar, D; Advani, SH; Bajpai, S; Gopal, R; Nair, CN; Saikia, T | 1 |
| Clausen, NT; Hansen, PB; Larsen, CR | 1 |
| Juliusson, G; Liliemark, J | 2 |
| Beran, M; Estey, EH; Hirsch-Ginsberg, C; Huh, YO; Kantarjian, HM; Keating, MJ; Koller, C; Kurzrock, R; McCredie, KB; O'Brien, SM | 1 |
| Hagberg, H | 1 |
| Carrera, CJ; Carson, DA; Cottam, HB; Esparza, LM; Kipps, TJ; Wasson, DB | 1 |
| Nightingale, SL | 1 |
| Daly, K; Golomb, HM; Mick, R; Ratain, MJ | 1 |
| Cheson, BD | 1 |
| Beutler, E; Carrera, CJ; Carson, DA; Piro, LD; Saven, A; Terai, C | 1 |
| Blatt, LM; Ozes, ON; Reiter, Z; Taylor, MW; Tomson, S | 1 |
| Golde, DW; Lill, MC | 1 |
| Gutterman, JU; Kurzrock, R; Talpaz, M | 1 |
| Beutler, E; Carrera, CJ; Carson, DA; Piro, LD | 1 |
| Beutler, E; Carrera, CJ; Carson, DA; Piro, LD; Wasson, DB | 1 |
7 review(s) available for 2-chloroadenosine and Leukemia, Hairy Cell
| Article | Year |
|---|---|
Advances in therapy for hairy cell leukemia. A review.
Topics: 2-Chloroadenosine; Deoxyadenosines; Forecasting; Granulocyte Colony-Stimulating Factor; Humans; Interferons; Leukemia, Hairy Cell; Male; Pentostatin; Splenectomy; Vidarabine | 1993 |
2-Chlorodeoxyadenosine: hairy cell leukemia takes a surprising turn.
Topics: 2-Chloroadenosine; Apoptosis; Humans; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphocytes; Lymphoma | 1993 |
Hairy cell leukemia. What is new forty years after the first description?
Topics: 2-Chloroadenosine; Antigens, CD; Antimetabolites, Antineoplastic; Antineoplastic Agents; B-Lymphocytes; Bone Marrow; Clinical Trials as Topic; Deoxyadenosines; Humans; Immunologic Factors; Interferon Type I; Leukemia, Hairy Cell; Neoplasm Proteins; Neoplasms, Second Primary; Neoplastic Stem Cells; Pentostatin; Receptors, Antigen, T-Cell, gamma-delta; Recombinant Proteins; Splenectomy; Vidarabine | 1998 |
The treatment of hairy cell leukemia: an update.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Splenectomy | 1992 |
Treatment of hairy-cell leukemia.
Topics: 2-Chloroadenosine; Antibody Formation; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Deoxyadenosines; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon Type I; Leukemia, Hairy Cell; Pentostatin; Remission Induction; Retrospective Studies; Splenectomy | 1990 |
Hairy cell leukaemia: review of treatment.
Topics: 2-Chloroadenosine; Cladribine; Deoxyadenosines; Granulocyte Colony-Stimulating Factor; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin; Splenectomy | 1991 |
Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
Topics: 2-Chloroadenosine; Adenosine Deaminase; Anemia, Hemolytic, Autoimmune; Cladribine; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell | 1989 |
3 trial(s) available for 2-chloroadenosine and Leukemia, Hairy Cell
| Article | Year |
|---|---|
Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
Topics: 2-Chloroadenosine; Antimetabolites, Antineoplastic; Bone Marrow; Deoxyadenosines; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasms, Second Primary; Splenomegaly; Survival Rate; Time Factors | 1997 |
2-CdA in the treatment of hairy cell leukaemia.
Topics: 2-Chloroadenosine; Adult; Antimetabolites, Antineoplastic; Deoxyadenosines; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neutropenia; Survival Rate; Treatment Outcome | 2001 |
Treatment of hairy-cell leukemia.
Topics: 2-Chloroadenosine; Antibody Formation; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Deoxyadenosines; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon Type I; Leukemia, Hairy Cell; Pentostatin; Remission Induction; Retrospective Studies; Splenectomy | 1990 |
26 other study(ies) available for 2-chloroadenosine and Leukemia, Hairy Cell
| Article | Year |
|---|---|
Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
Topics: 2-Chloroadenosine; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxyadenosines; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Retreatment; Splenectomy; Treatment Outcome | 2010 |
Bilateral facial nerve palsy as first indication of relapsing hairy cell leukemia after 36 years.
Topics: 2-Chloroadenosine; Aged; Antimetabolites, Antineoplastic; Arm; Deoxyadenosines; Diagnosis, Differential; Diplopia; Facial Paralysis; Female; Humans; Hypesthesia; Leukemia, Hairy Cell; Lymph Nodes; Recurrence; Remission Induction; Stroke; Survivors | 2004 |
Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab.
Topics: 2-Chloroadenosine; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Combined Modality Therapy; Cyclophosphamide; Deoxyadenosines; Disease Progression; Drug Resistance, Neoplasm; Fatal Outcome; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Neoplasms, Second Primary; Prednisolone; Recurrence; Red-Cell Aplasia, Pure; Remission Induction; Rituximab; Splenectomy; Urinary Bladder Neoplasms | 2005 |
Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly.
Topics: 2-Chloroadenosine; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antimetabolites, Antineoplastic; Deoxyadenosines; Female; Humans; Leukemia, Hairy Cell; Treatment Outcome | 2008 |
Fulminant hepatitis C virus infection.
Topics: 2-Chloroadenosine; Alanine Transaminase; Clinical Enzyme Tests; Deoxyadenosines; Female; Hepatitis C; Humans; Leukemia, Hairy Cell; Middle Aged; Transfusion Reaction | 1994 |
Bone marrow trephines. Findings in patients with hairy cell leukaemia before and after treatment.
Topics: 2-Chloroadenosine; Adult; Aged; Biopsy; Bone Marrow; Female; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged | 1994 |
Rapid massive splenic relapse of hairy cell leukemia (HCL) during bone marrow remission after 2-chlorodeoxyadenosine therapy: the spleen as a sanctuary site in HCL?
Topics: 2-Chloroadenosine; Aged; Bone Marrow; Female; Humans; Leukemia, Hairy Cell; Neoplasm Recurrence, Local; Remission Induction; Splenomegaly | 1994 |
Red cell distribution width (RDW) as a marker of disease activity in patients with hairy cell leukemia.
Topics: 2-Chloroadenosine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Deoxyadenosines; Erythrocyte Indices; Female; Hemoglobins; Humans; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction; Splenectomy | 1998 |
Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia.
Topics: 2-Chloroadenosine; Antimetabolites, Antineoplastic; Deoxyadenosines; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Leukemia, Hairy Cell; Receptors, Interleukin-1; Receptors, Interleukin-1 Type II; Severity of Illness Index; Sialoglycoproteins | 1998 |
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.
Topics: 2-Chloroadenosine; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biomarkers, Tumor; Deoxyadenosines; Female; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Proto-Oncogene Proteins c-bcl-2; Vidarabine | 1998 |
[2-CDA in treatment of hairy cell leukemia: a comparison between intravenous and subcutaneous administration. Swiss Study Group of Applied Cancer Research].
Topics: 2-Chloroadenosine; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cohort Studies; Deoxyadenosines; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leukemia, Hairy Cell; Male; Middle Aged; Pilot Projects; Prospective Studies; Remission Induction; Treatment Outcome | 1998 |
The tumor necrosis factor family and and correlation with disease activity and response to treatment in hairy cell leukemia.
Topics: 2-Chloroadenosine; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Neoplasm, Residual; Prognosis; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 1999 |
Peliosis hepatis after treatment with 2-chloro-3'-deoxyadenosine.
Topics: 2-Chloroadenosine; Aged; Antineoplastic Agents; Deoxyadenosines; Female; Humans; Leukemia, Hairy Cell; Peliosis Hepatis | 2000 |
Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues.
Topics: 2-Chloroadenosine; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nucleosides; Vidarabine | 2002 |
Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Candidiasis; Cladribine; Cytomegalovirus Infections; Deoxyadenosines; Humans; Immunophenotyping; Leukemia, Hairy Cell; Leukopenia; Lymphocytes; Monocytes; Neutrophils; Opportunistic Infections; Remission Induction; Thrombocytopenia | 1992 |
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Drug Resistance; Humans; Leukemia, Hairy Cell; Leukocyte Count; Leukopenia; Male; Middle Aged; Neutrophils; Platelet Count; Remission Induction; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 1992 |
[Alpha interferon treatment in hairy cell leukemia].
Topics: 2-Chloroadenosine; Cladribine; Deoxyadenosines; Drug Therapy, Combination; Humans; Interferon-alpha; Leukemia, Hairy Cell; Pentostatin | 1992 |
Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.
Topics: 2-Chloroadenosine; Adenine Nucleotides; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Cell Death; Cladribine; Clofarabine; Deoxyadenosines; DNA; DNA Damage; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Mice; Mice, SCID; Monocytes | 1992 |
From the Food and Drug Administration.
Topics: 2-Chloroadenosine; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents; Antitubercular Agents; Cladribine; Deoxyadenosines; Drugs, Investigational; Equipment and Supplies; Fetus; Humans; Leukemia, Hairy Cell; Mycobacterium avium-intracellulare Infection; Product Surveillance, Postmarketing; Rifabutin; Rifamycins; United States; United States Food and Drug Administration | 1992 |
Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Neoplasms | 1992 |
Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Pentostatin; Vidarabine | 1992 |
Lymphoma, hairy-cell leukemia respond to new agents.
Topics: 2-Chloroadenosine; Antibodies, Monoclonal; Deoxyadenosines; Humans; Immunoconjugates; Immunotoxins; Leukemia, Hairy Cell; Lymphoma; Pentostatin; Ricin | 1992 |
[A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases].
Topics: 2-Chloroadenosine; Cladribine; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Lymphoproliferative Disorders | 1991 |
2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes.
Topics: 2-Chloroadenosine; Cell Death; Cladribine; Deoxyadenosines; DNA; DNA Damage; Humans; In Vitro Techniques; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Nucleosomes; Reference Values | 1991 |
A dual anti-tumor effect of a combination of interferon-alpha and 5-flurouracil or 2-chlorodeoxyadenosine on natural killer (NK) cell mediated cytotoxicity.
Topics: 2-Chloroadenosine; Acquired Immunodeficiency Syndrome; Antimetabolites, Antineoplastic; Cell Division; Cell Line; Cladribine; Cytotoxicity, Immunologic; Deoxyadenosines; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluorouracil; Humans; Interferon Type I; Killer Cells, Natural; Kinetics; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Recombinant Proteins; Sarcoma, Kaposi; Uterine Cervical Neoplasms | 1991 |
Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
Topics: 2-Chloroadenosine; Adult; Antineoplastic Agents; Bone Marrow; Cladribine; Deoxyadenosines; Female; Humans; Infusions, Parenteral; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction | 1990 |